Who owns MAIA BIOTECHNOLOGY INC?
- Ticker: MAIA
- CUSIP Number: 552641102
Tip: Access positions for across all investors
Analyze quarterly positions in Maia Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Maia Biotechnology stock
Who bought or sold MAIA BIOTECHNOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 2.1M | $2.9M | 100% | Mar 2026 |
|
| Vanguard Group | 1.2M | $1.8M | 5% | Dec 2025 |
|
| Centric Wealth Management | 797k | $1.1M | 36% | Mar 2026 |
|
| Geode Capital Management | 297k | $454k | 9% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 199k | $279k | 100% | Mar 2026 |
|
| BlackRock | 128k | $179k | 19% | Mar 2026 |
|
| State Street Corporation | 76k | $116k | 0% | Dec 2025 |
|
| UBS Group | 52k | $73k | 2292% | Mar 2026 |
|
| Northern Trust | 39k | $60k | 0% | Dec 2025 |
|
| Bridgeway Capital Management | 36k | $55k | 0% | Dec 2025 |
|
| Creative Planning | 29k | $40k | -1% | Mar 2026 |
|
| Comprehensive Portfolio Management | 23k | $32k | 0% | Mar 2026 |
|
| O'shaughnessy Asset Management | 20k | $28k | 100% | Mar 2026 |
|
| Centerpoint Advisory Group | 16k | $22k | 0% | Mar 2026 |
|
| Susquehanna International | 14k | $22k | 23% | Dec 2025 |
|
| Vanguard Global Advisers | 11k | $16k | 100% | Mar 2026 |
|
| Catalyst Funds Management Pty | 11k | $15k | 100% | Mar 2026 |
|
| Cambridge Investment Research Advisors | 11k | $15k | 0% | Mar 2026 |
|
| Intl Fcstone | 10k | $16k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 8.3k | $13k | 0% | Dec 2025 |
|
| Daytona Street Capital | 7.5k | $10k | 100% | Mar 2026 |
|
| Curio Wealth | 2.0k | $2.8k | 0% | Mar 2026 |
|
| MAI Wealth Advisors | 675.00 | $1.0k | 0% | Dec 2025 |
|
| Tucker Asset Management | 341.00 | $522.002800 | 100% | Dec 2025 |
|
| Jones Financial Companies, L.L | 228.00 | $348.999600 | 0% | Dec 2025 |
|
| Citigroup | 22.00 | $31.000200 | 100% | Mar 2026 |
|
Who sold out of Maia Biotechnology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Sep 2025 | 111k | $170k |
| Jane Street | Dec 2025 | 79k | $121k |
| Wealth Enhancement Advisory Services | Dec 2025 | 15k | $23k |
| Tower Research Capital | Sep 2025 | 4.0k | $6.2k |
| Rocky Mountain Advisers | Dec 2025 | 653.00 | $999.024700 |